Search Results
Results found for "Howard Hughes"
- GPR3 expression in retinal ganglion cells contributes to neuron survival and accelerates axonal...
Surprisingly, RGCs in GPR3 knockout mice were vulnerable to neural death during aging without affecting high
- 📰 GPCR Weekly News
Establishment of a CaCC-based Cell Model and Method for High-throughput Screening of M3 Receptor Drugs High-performance optical control of GPCR signaling by bistable animal opsins MosOpn3 and LamPP in a molecular
- Glucagon receptor-mediated regulation of gluconeogenic gene transcription is endocytosis-dependent..
We show that epitope-tagged GCGRs undergo clathrin- and dynamin-dependent endocytosis in HEK293 and Huh
- A Model for the Signal Initiation Complex Between Arrestin-3 and the Src Family Kinase Fgr
Previous reports demonstrated that Fgr exhibits high constitutive activity, but can be further activated
- Co-activation of GPCRs facilitate GIRK-dependent current
The results indicate that a low tonic level of G βγ results in facilitation of GIRK current and a high
- 📰 GPCR Weekly News, February 20 to 26, 2023
modulation of conserved motifs and helices in 5HT2BR: Advances drug discovery and therapeutic approach towards
- Conjugation Strategies for Probe Development
For our very first post in this ecosystem, we wanted to highlight a huge part of our work at Celtarys
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
Redefine Your Pipeline If your development program is built around potency alone, you may be leaving high-value
- The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway
Here’s how it happens: 1️⃣ Duplicated effort 👉 Two teams think they’re building toward the same milestone
- Genome-wide identification of 216 G protein-coupled receptor (GPCR) genes from the marine water ...
Homo sapiens), fruitfly (Drosophila melanogaster), and freshwater water flea (Daphnia magna) reveals a high
- Chemokine receptor-targeted drug discovery: progress and challenges
Drug discovery is shifting towards the development of biased ligands, which promote the engagement of
- Novel interaction between neurotrophic factor-α1/carboxypeptidase E and serotonin receptor, 5-HTR1E,
interaction between NFα1/CPE and 5-HTR1E and 125I NF-α1/CPE-binding studies demonstrated saturable, high-affinity
- The Real Cost of Strategic Overload in Biotech
Milestones no longer build toward a single dominant value inflection point.
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
Kenakin’s latest lecture delivers high-impact insight crafted for teams navigating the complex behaviors
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
differential endoplasmic reticulum environment amongst neuronal subtypes Methods & Updates in GPCR Research High-throughput
- 📰 GPCR Weekly News, July 3 to 9, 2023
Research Profiling of basal and ligand-dependent GPCR activities by means of a polyvalent cell-based high-throughput
- Scientific Isolation: The Real Reason Early Biotechs Lose Traction
No blow-ups.Just a gradual slide into a world where the internal noise is high, but the external signal
- G protein-coupled receptor interactions and modification of signalling involving the ghrelin ...
At some sites, such as at somatotrophs, GHSR1a has high constitutive activity.
- In vivo metabolic effects after acute activation of skeletal muscle G s signaling
We also identified two Gs-coupled GPCRs that are endogenously expressed by SKM at relatively high levels
- How Schild Analysis Protects Your Conclusions in GPCR Research
translational pharmacologists, biotech discovery teams, and decision-makers who need concise, credible, high-value
- The Hidden Cost of Unclear Biotech Positioning
The effort shifts away from persuasion and toward alignment , which reduces friction across every interaction
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
. - High-throughput applications Bright and stable fluorescent ligands can be used in HTS,
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
Forge high-value connections in an intimate setting.
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
That’s exactly what Terry’s Corner delivers this week: high-impact insight into GPCR allostery, crafted
- Better GPCR Drug Discovery Decisions Start With Structured Learning
Assess hepatotoxicity risk—anticipate reactive metabolites and high-risk drug–drug interactions.
- Adhesion GPCR Consortium Newsletter - May 2024
A small step toward leveling the playing field.
- 📰 GPCR Weekly News, January 30 to February 5, 2023
The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards
- Odorant receptors – a bit of smell for drug discovery
The development of antibodies directed towards an OR could either drive receptor inactivation or activation
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
Where high-throughput screening saw chaos, Ajay saw patterns waiting to be decoded.
- Curve Shifts Don’t Lie, But Your Eyes Might
For high-throughput screens where sensitivity isn’t critical, you’ll save time by running fewer replicates

















